Datamonitor's Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
Scope of the Report
* Contains an executive summary and data on value and segmentation
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
* Covers Global, European, Asia-Pacific & 11 individual country markets
* Includes a five-year forecast of the industry
Highlights
The global generics market generated total revenues of $57.8 billion in 2005, an increase of 20.9% since 2004, representing a compound annual growth rate (CAGR) of 18.2% for the five-year period spanning 2001-2005.
Ethical generic sales proved the most lucrative for the global market in 2005, generating total revenues of $44.3 billion, equivalent to 76.6% of the market‘s overall value.
Looking forward, the market is forecast to grow at a very healthy rate and improve its performance, with an anticipated CAGR of 16% for the five-year period 2005-2010 expected to drive the market to a value of $121.3 billion by the end of 2010.
Why you should buy this report:
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Definition
The value of the generics market consists of all sales of generics drugs at exmanufacturers prices. The market does not include consumer healthcare products, nor animal healthcare. Datamonitor defines a generic as a product, which is an officially approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name. This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. All currency conversions have been calculated at constant 2005 average exchange rates.
For the purpose of this report, Europe is deemed to consist of Belgium, France, Germany, Italy, Netherlands, Spain and the UK.
Asia-Pacific consists of the Chinese and Japanese markets.
The Americas is composed of Canada and the United States.
The global market is deemed to be Asia-Pacific, Europe and the Americas.
Note:
The report listed above is published by
Datamonitor, a third party not affiliated with The Healthcare Sales & Marketing Network.
Datamonitor is solely responsible for its content.
Customers who purchased this report also looked at:
Public
Feeds 
